The relationship between resting heart rate and atherosclerosis risk factors

Kardiologia Polska

Volumn 66, Issue 10, 2008, Pages 1069-1075

  Piwońska, Aleksandra ^a   Piotrowski, Walerian ^a   Broda, Grazyna ^a   Drygas, Wojciech ^b   Głuszek, Jerzy ^c   Zdrojewski, Tomasz ^d   Kozakiewicz, Krystyna ^e   Stepaniak, Urszula ^f   Bandosz, Piotr ^d  

^a INSTITUTE OF CARDIOLOGY   (Poland)

^b MEDICAL UNIVERSITY OF LODZ   (Poland)

^c POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^d MEDICAL UNIVERSITY OF GDANSK   (Poland)

^e MEDICAL UNIVERSITY OF SILESIA   (Poland)

^f JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Diabetes; Hypertension; Obesity; Resting heart rate

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; GLUCOSE; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH SURVEY; HEART INFARCTION; HEART RATE; HOSPITALIZATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; OBESITY; PREVALENCE; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; SMOKING HABIT; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 55049134995     PISSN: 00229032     EISSN: 00229032     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Kannel WB, Kannel C, Paffenburger RS. Heart rate and cardiovascular mortality. The Framingham Study. Am Heart J 1987; 6: 1489-94.
2. Gillum RF, Makuc DM, Feldman JJ. Pulse rate, coronary heart disease and death.: The NHANES I Epidemiologic Follow-up Study. Am Heart J 1991; 121: 172-7.
3. Shaper AG, Wannamethee G, Mc Farlane PW, et al. Heart rate, isch emic heart disease, and sudden cardiac death in middle-aged British men. Br Heart J 1993; 70: 49-55.
4. Diaz A, Bourassa MG, Guertin MC, et al. Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease. Eur Heart J 2005; 26: 967-74.
5. Pytlak A, Piotrowski W, Broda G. Zależność pomiȩdzy czȩstościa̧ tȩtna a umieralnościa̧ ogólna̧ i spowodowanav chorobami układu kra̧żenia. Przegl Lek 1997; 54: 25-30.
6. Kjekhus JK. Importance of heart rate in determining beta-blockers efficacy in acute and long-term myocardial intervention trials. Am J Cardiol 1986; 57: 43F.
7. Filipiak KJ, Szmit S. Spoczynkowa czynność serca - wcia̧ż niedoceniany czynnik ryzyka. Kardiologia po Dyplomie 2006; 5: 10-29.
8. Perski A, Hamsten A, Lindval K, et al. Heart rate correlates with severity of coronary artherosclerosis in young postinfarction patients. Am Heart J 1988; 116: 1369-73.
9. Palatini P. Office versus ambulatory heart rate in the prediction of cardiovascular risk. Blood Press Monit 1998; 3: 153-6.
10. Broda G, Rywik S. Wieloośrodkowe ogólnopolskie badanie stanu zdrowia ludności - project WOBASZ. Zdefiniowanie problemu oraz cele badania. Kardiol Pol 2005; 63: (suppl. 4): S601-S604.
11. Rywik S, Kupść W, Piotrowski W, et al. Wielooś rodkowe ogólnopolskie badanie stanu zdrowia ludności - projekt WOBASZ. Założenie metodyczne oraz logistyka. Kardiol Pol 2005; 63: (suppl. 4): S605-S613.
12. Levine HJ. Rest heart rate and life expectancy. J Am Coll Cardiol 1997; 30: 1104-6.
13. Beere P, Glagov S, Zarins CK. Retarding effect of lowered heart rate on coronary atherosclerosis. Science 1984; 226: 180-2.
14. Kaplan JR, Manuck SB, Adams MR, et al. Inhibition of coronary atherosclerosis by propranolol in behaviorally predisposed monkeys fed an atherpogenic diet. Circulation 1987; 76: 1364-72.
15. Hedblad B, Wikstrand J, Janzon L, et al. Low dose metoprolol CR/XL and fluvastatin slow progression of carotid intima-media thickness: main results from the Beta-Blocker Cholesterol-Lowering Asymptomatic Plague Study (BCAPS). Circulation 2001; 103: 1721-6.
16. Rogowski O, Shapira I, Shirom A, et al. Heart rate and microinflammation in men: a relevant atherothrombotic link. Heart 2007; 93: 940-4.
17. van Westerloo DJ, Giebelen IA, Meijers JC, et al. Vagus nerve stimulation inhibits activation of coagulation and fibrinolysis during endotoxemia in rats. J Thromb Haemost 2006; 4: 1997-2002.
18. Bonaa KM, Arnesen E. Association between heart rate and atherogenic blood lipid fractions in a population. The Thromsø Study. Circulation 1992; 86: 394-405.
19. Landsberg L, Young YB. Fasting, feeding and regulation of the sympathetic nervous system. N Engl J Med 1978; 298: 1295-301.
20. Gillum RF. The epidemiology of resting heart rate in a national sample of men and women: Associations with hypertension, coronary heart disease, blood pressure and other cardiovascular risk factors. Am Heart J 1988; 116: 163.
21. Urbanlil-Rovan V, Meglil B, Stefanovska A, et al. Incipient cardiovascular autonomic imbalance revealed by wavelet analysis of heart rate variability in type 2 diabetic patients. Diabet Med 2007; 24: 18-26.
22. Hayano J, Sakakibaro Y, Yamada M, et al. Decreased magnitude of heart rate spectral components in coronary artery disease. Its relation to angiographic severity. Circulation 1990; 81: 1217-24.
23. Festa A, D'Agostino R Jr, Hales CN, et al. Heart rate in relation to insulin sensitivity and insulin secretion in nondiabetic subjects. Diabetes Care 2000; 23: 624-8.
24. Facchini FS, Stoohs RA, Reaven GM. Enhanced sympathetic nervous system activity. The linchpin between insulin resistance, hyperinsulinemia, and heart rate. Am J Hypertens 1996; 9: 1013-7.
25. Grynberg A, Ziegler D, Rupp H. Sympathoadrenergic overactivity and lipid metabolism. Cardiovsc Drugs Ther 1996; 10: 223-30.